The present invention relates to novel pyrrolo[3,2-c]pyridine-6-amino derivatives that inhibit the spindle checkpoint function of Monospindle 1 (Mps1 – also known as TTK) kinases. In particular, the present invention relates to isopropyl 6-(2-methoxy-4-(1-5 methyl-1H-1,2,3-triazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2- c]pyridine-1-carboxylate and isopropyl 6-(2-methoxy-4-(1-methyl-1H-tetrazol-5- yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate and their use as therapeutic agents for the treatment and/or prevention of proliferative diseases, such as cancer. The present invention also relates to processes for the 10 preparation of these compounds and to pharmaceutical compositions comprising them.
本发明涉及一种新的
吡咯并[3,2-c]
吡啶-6-
氨基衍
生物,其抑制单丝粒体1(Mps1 - 也称为
TTK)激酶的纺锤体检查点功能。具体而言,本发明涉及异丙基6-(2-甲氧基-4-(1-5 甲基-
1H-1,2,3-三唑-5-基)
苯胺基)-2-(1-甲基-1H-
吡唑-4-基)-1H-
吡咯并[3,2-c]
吡啶-1-
羧酸异
丙酯和异丙基6-(2-甲氧基-4-(
1-甲基-1H-四唑-5- 基)
苯胺基)-2-(1-甲基-1H-
吡唑-4-基)-1H-
吡咯并[3,2-c]
吡啶-1-
羧酸异
丙酯及其作为治疗和/或预防增殖性疾病(如癌症)的治疗剂的用途。本发明还涉及制备这些化合物的方法以及包含它们的药物组合物。